'We don't set the price. Pharmaceutical manufacturers set the price'.
Pharmacy benefit managers are facing heat for not doing enough to slow down drug price hikes. UnitedHealth Group's subsidiary, OptumRx, recently acquired Catamaran Corp. for almost $13 billion, making it the third-largest PBM in the country by market share. Modern Healthcare Midwest Bureau Chief Bob Herman recently asked OptumRx. CEO Mark Thierer about the controversy swirling around the industry. The following is an edited excerpt.